Open AccessCapabilities of combined peptide drugs in the correction of male infertility (literature review)
Author(s) -
Yaroslav Valerievich Prokopiev,
A.R. Abdrakhmanov
Publication year - 2021
Publication title -
consilium medicum
Language(s) - English
Resource type - Journals
eISSN - 2542-2170
pISSN - 2075-1753
DOI - 10.26442/20751753.2021.12.201295
Subject(s) - infertility , genitourinary system , male infertility , sperm , fertility , medicine , male fertility , physiology , immunology , gynecology , biology , andrology , population , pregnancy , genetics , environmental health
Acute and chronic urogenital infections are associated with male infertility. Besides "traditional" sexually transmitted infections, there is a significant increase in inflammatory diseases of reproductive system caused by opportunistic pathogens. Studies show that sperm fertility is influenced by direct exposure to sexually transmitted infections, as well as dysfunction of the blood-testicular barrier, leading to autoimmune infertility. In a number of clinical trials, Prostatilen AC was shown to have benefitial effects on the ejaculate.